Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Gangolli Julian S Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 370,282 options to buy @ $0.24, valued at $88.9k
07/03/2023 4 Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Granted 6,800 options to buy @ $117.4, valued at $798.3k
05/05/2023 4 Gangolli Julian S (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 3,534 shares @ $0
Granted 5,915 options to buy @ $33.61, valued at $198.8k
03/31/2023 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 41,065 options to buy @ $1.05, valued at $43.1k
10/07/2022 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 74,398 options to buy @ $1.25, valued at $93k
07/01/2022 4 Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Granted 6,800 options to buy @ $65.66, valued at $446.5k
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/24/2022 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 21,878 options to buy @ $1.92, valued at $42k
10/07/2021 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 44,466 options to buy @ $2.12, valued at $94.3k
07/02/2021 4 Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Granted 6,800 options to buy @ $68, valued at $462.4k
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/07/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 125,000 options to buy @ $1.58, valued at $197.5k
07/06/2020 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 35,006 options to buy @ $1.28, valued at $44.8k
05/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2020 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.72, valued at $18k
05/14/2019 4 Gangolli Julian S (President, North America) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Exercised 403,804 shares @ $0.0013, valued at $524.9
Exercised 75,369 shares @ $10.61, valued at $799.7k
Exercised 192,755 shares @ $3.72, valued at $717k
Sold 117,876 shares @ $14.63, valued at $1.7M
Sold 81,156 shares @ $14.7, valued at $1.2M
Sold 65,268 shares @ $14.8, valued at $966k
Sold 208,260 shares @ $14.88, valued at $3.1M
Sold 145,164 shares @ $14.96, valued at $2.2M
Sold 12,048 shares @ $15.03, valued at $181.1k
Sold 31,368 shares @ $15.12, valued at $474.3k
Sold 10,788 shares @ $15.19, valued at $163.9k
05/10/2019 4 Gangolli Julian S (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 4,500 shares @ $0
Granted 9,000 options to buy @ $12.82, valued at $115.4k
03/06/2019 4 Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Granted 20,000 options to buy @ $22.75, valued at $455k
02/28/2019 4 Gangolli Julian S (President, North America) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Exercised 11,256 shares @ $0.0013, valued at $14.6
Sold 5,952 shares @ $12.45, valued at $74.1k
Sold 48 shares @ $12.37, valued at $593.8
Exercised 11,256 options @ $0
05/11/2018 4 Gangolli Julian S (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 3,000 shares @ $0
Granted 6,000 options to buy @ $29.15, valued at $174.9k
05/12/2017 4 Gangolli Julian S (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 3,000 shares @ $0
Granted 6,000 options to buy @ $20.9, valued at $125.4k
07/06/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/19/2015 4 Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC
Txns: Gifted 20,078 shares @ $0
Gifted 2,095 shares @ $0
Granted 7,892 shares @ $0
Disposed/sold 220 shares @ $0
Disposed/sold 265 shares @ $0
Disposed/sold 7,946 shares @ $0
Disposed/sold 60,000 options to buy @ $64.47, valued at $3.9M
Disposed/sold 12,500 options to buy @ $59.13, valued at $739.1k
Disposed/sold 52,000 options to buy @ $75.58, valued at $3.9M
Disposed/sold 38,000 options to buy @ $87.91, valued at $3.3M
Disposed/sold 15,000 options to buy @ $87.91, valued at $1.3M
02/24/2015 4 Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC
Txns: Paid exercise price by delivering 269 shares @ $234, valued at $62.9k
Granted 514 restricted stock units @ $0
Exercised 514 restricted stock units @ $0
02/19/2015 4 Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC
Txns: Paid exercise price by delivering 1,150 shares @ $230.15, valued at $264.7k
03/07/2014 4 Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC
Txns: Gifted 3,120 shares @ $0
Gifted 3,120 shares @ $0
02/25/2014 4 Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC
Txns: Paid exercise price by delivering 1,880 shares @ $125.07, valued at $235.1k
Granted 40,729 options to buy @ $125.07, valued at $5.1M
12/30/2013 4 Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC
Txns: Sold 15,000 shares @ $110.17, valued at $1.7M
Sold 37,500 shares @ $110, valued at $4.1M
Exercised 15,000 options to buy @ $40.16, valued at $602.4k
Exercised 37,500 options to buy @ $59.13, valued at $2.2M
03/04/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
02/22/2013 4 Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC
Txns: Paid exercise price by delivering 2,699 shares @ $108.08, valued at $291.7k
Granted 20,000 options to buy @ $105.87, valued at $2.1M
Granted 40,000 options to buy @ $105.87, valued at $4.2M
01/14/2013 4 Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC
Txns: Gifted 401 shares @ $0
Gifted 401 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy